Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05707806 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development and Validation of Learning and Decision-Making Tasks

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 75 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Eligibility criteria expanded, about 15 words
  3. Minor 2 versions Re-verified since May 28, 2026, no change to tracked fieldsv72-v73
  4. Minor Eligibility criteria revisedv71 See this version in full on ClinicalTrials.gov ↗
  5. Minor Eligibility criteria shortened, about 1 wordv70 See this version in full on ClinicalTrials.gov ↗
Show 44 earlier versionsHide 44 earlier versions
  1. Minor 9 versions Re-verified since Mar 1, 2025, no change to tracked fieldsv61-v69
  2. Minor Eligibility criteria expanded, about 1 wordv60 See this version in full on ClinicalTrials.gov ↗
  3. Minor Re-verified, no change to tracked fieldsv59
  4. Minor Eligibility criteria expanded, about 37 wordsv58 See this version in full on ClinicalTrials.gov ↗
  5. Minor 2 versions Re-verified since Sep 7, 2024, no change to tracked fieldsv56-v57
  6. Minor Eligibility criteria expanded, about 7 wordsv55 See this version in full on ClinicalTrials.gov ↗
  7. Minor Study Status, Study Description, Contacts/Locationsv54
  8. Minor Re-verified, no change to tracked fieldsv53
  9. Minor Study Status, Study Descriptionv52
  10. Minor 2 versions Re-verified since May 15, 2024, no change to tracked fieldsv50-v51
  11. Minor Eligibility criteria expanded, about 55 wordsv49 See this version in full on ClinicalTrials.gov ↗
  12. Minor 2 versions Re-verified since Dec 15, 2023, no change to tracked fieldsv47-v48
  13. Minor Eligibility criteria expanded, about 30 wordsv46 See this version in full on ClinicalTrials.gov ↗
  14. Minor 2 versions Re-verified since Nov 9, 2023, no change to tracked fieldsv44-v45
  15. Minor Eligibility criteria expanded, about 30 wordsv43 See this version in full on ClinicalTrials.gov ↗
  16. Minor 3 versions Re-verified since Jun 9, 2023, no change to tracked fieldsv40-v42
  17. Minor Start date changed from estimate of Apr 6, 2023 to Mar 29, 2023v39
  18. Minor Start date: Apr 4, 2023 to Apr 6, 2023v38
  19. Minor Start date: Apr 3, 2023 to Apr 4, 2023v37
  20. Minor Start date: Mar 31, 2023 to Apr 3, 2023v36
  21. Minor Start date: Mar 30, 2023 to Mar 31, 2023v35
  22. Minor Start date: Mar 28, 2023 to Mar 30, 2023v34
  23. Minor Start date: Mar 27, 2023 to Mar 28, 2023v33
  24. Minor Start date: Mar 24, 2023 to Mar 27, 2023v32
  25. Minor Start date: Mar 22, 2023 to Mar 24, 2023v31
  26. Minor Start date: Mar 21, 2023 to Mar 22, 2023v30
  27. Minor Start date: Mar 20, 2023 to Mar 21, 2023v29
  28. Minor Start date: Mar 19, 2023 to Mar 20, 2023v28
  29. Minor Start date: Mar 16, 2023 to Mar 19, 2023v27
  30. Minor Start date: Mar 15, 2023 to Mar 16, 2023v26
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Substance use disorders (SUD) can be considered disorders in the way people process incentives, learn, and make decisions. To understand why some people develop SUD, researchers need to develop reliable tests that show how people think and learn. This natural history study seeks to develop a set of tasks that could then be used to test how people learn and make decisions. Objective: To develop and validate behavioral tasks that could be used in future studies. Eligibility: Healthy people aged 18-45 years from the Baltimore area. They must also be enrolled in the NIDA screening protocol. Design: Participants will perform different tasks. Most tasks require 1-4 study visits; some may require up to 12. Visits are 1-14 days apart. All visits will last about 1-7 hours. Participants will perform tasks on a computer. As they work they may be given different stimuli: Smells. Participants will sniff odors through a plastic tube or mask on their nose. Flavors. Participants will wear a mouthpiece and small amounts of different flavored liquids will be placed in their mouth. Pictures. Participants will look at different images. Sounds. Participants will wear headphones and various sounds will be played for them. Food. Participants may be asked to eat a meal before, during, or after a task. The researchers will provide the meal. During each task, participants will wear sensors to monitor their heart rate, blood pressure, breathing, and other physical changes in their bodies. Some participants will have a functional magnetic resonance imaging (fMRI) scan. They will lie on a table that slides into a cylinder. They will perform tasks on a computer screen during the fMRI.
Trial Details
NCT Number NCT05707806
Lead Sponsor National Institute on Drug Abuse (NIDA)
Conditions Normal Physiology
Enrollment 550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov